PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 8, 2026ACS Applied Materials & Interfaces0 citations

Water-Dispersible Plasmonic Gold Nanoparticle Vesicle as a Drug Delivery Carrier for Cancer Therapy

View Full Paper
JWJinjian WeiXWXinjie WangHXH. K. Xu

Key Points

  • The research aims to develop and evaluate a gold nanoparticle vesicle system for effective drug delivery in cancer therapy.
  • Fabrication of plasmonic gold nanoparticle vesicles using TrOFBL ligands
  • Transfer of GNVs from tetrahydrofuran to aqueous solution
  • Encapsulation of a hydrophobic anticancer drug with high loading efficiency
  • In vitro cellular assays to test drug release and cytotoxicity
  • In vivo tests to evaluate tumor growth inhibition and toxicity
  • GNVs demonstrated a drug loading efficiency of 74%
  • Upon laser irradiation, drug release reached up to 99%
  • GNVs were efficiently internalized by cancer cells and induced cytotoxicity
  • Laser-triggered release showed effective tumor growth inhibition in vivo
  • No noticeable systemic toxicity was observed during treatments

Abstract

Fabrication of water-dispersible plasmonic gold nanoparticle vesicles (GNVs) by using small-molecule surface ligands for biological applications still remains a significant challenge. In this paper, we demonstrate that a tri(ethylene glycol) terminated octafluoro-4,4'-biphenol ligand (TrOFBL) can self-assemble with 5 or 10 nm gold nanoparticles into hollow-structured GNVs in tetrahydrofuran (THF). After the GNVs are transferred from THF to an aqueous solution, these single-layered plasmonic GNVs remain stable and dispersible. The precise control of the balance between hydrophilic and hydrophobic effects of the small-molecule ligand leads to the stabilization of the GNVs in water. The GNVs can encapsulate a hydrophobic anticancer drug in the interior with a high loading efficiency of 74%. Upon irradiation with a red laser (650 nm), the accumulative release of the drug can reach up to 99% due to the destruction of GNVs induced by local heating. Cellular assays confirm that the GNVs are efficiently internalized by cancer cells and release the drugs upon laser irradiation to induce cytotoxicity. In vivo anticancer result shows that the laser-triggered drug release effectively inhibits tumor growth after irradiation without noticeable systemic toxicity, making them suitable for in vivo tumor therapy.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Wei et al. (2026) studied this question.

synapsesocial.com/papers/698828770fc35cd7a8847ebehttps://doi.org/10.1021/acsami.5c22854
Ask AI
Helpful
Bookmark
Share
View Full Paper